Method for establishing rat premature ovarian failure model by utilizing cisplatin

A technology of premature ovarian failure and administration method, which is applied in the field of establishing premature ovarian failure models in rats, and can solve problems such as premature ovarian failure, ovarian cell apoptosis, and side effects

Inactive Publication Date: 2020-06-19
北京银丰鼎诚生物工程技术有限公司 +1
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, cisplatin has certain toxicity when used to treat cancer, and it will cause side effects, which are directly related to ovarian damage. Studies have shown that cisplatin can induce ovarian cell apoptosis, cause tissue necrosis, and lead to premature ovarian failure.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for establishing rat premature ovarian failure model by utilizing cisplatin
  • Method for establishing rat premature ovarian failure model by utilizing cisplatin
  • Method for establishing rat premature ovarian failure model by utilizing cisplatin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1: establish premature ovarian failure model in rats

[0024] The steps are as follows: add 50 ml of 0.9% sodium chloride solution into 10 mg medical cisplatin (Qilu Pharmaceutical, batch number: AA1A8029A), prepare 2 mg / kg cisplatin injection, and inject 10 ml / kg intraperitoneally continuously for 7 days.

Embodiment 2

[0025] Embodiment 2: establish premature ovarian failure model in rats

[0026] The steps are as follows: add 33.33ml of 0.9% sodium chloride solution to 10mg of medical cisplatin (Qilu Pharmaceutical, batch number: AA1A8029A) to prepare 3mg / kg cisplatin injection, and inject 10ml / kg intraperitoneally continuously for 7 days.

Embodiment 3

[0027] Embodiment 3 establishes premature ovarian failure model in rats

[0028] The steps are as follows: add 25ml of 0.9% sodium chloride solution to 10mg medical cisplatin (Qilu Pharmaceutical, batch number: AA1A8029A) to prepare 4mg / kg cisplatin injection, and inject 10ml / kg on the first day and the second day respectively. Intraperitoneal injection for eight days.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for establishing a rat premature ovarian failure model by utilizing cisplatin. The method comprises the following steps: applying the cisplatin with a dosage of 2-3 mg / Kg per day according to a body weight to a rat in an intraperitoneal injection mode, wherein the cisplatin application method is as follows: continuously applying the cisplatin for 7 days, and obtaining the rat premature ovarian failure model on the 15th day after the last injection; or applying the cisplatin with a dosage of 4-6 mg / Kg according to the body weight to the rat in an intraperitonealinjection mode, wherein the cisplatin application method is as follows: applying the cisplatin on the first day and the eighth day, and obtaining the rat premature ovarian failure model on the 15th day after the last injection. According to the invention, a chemotherapeutic injury premature ovarian failure animal model is established by using different concentrations of cisplatin and different application methods of the cisplatin; through comparison of advantages and disadvantages of the application methods of the cisplatin, the optimal concentration and administration time of the cisplatin are screened out; and an experimental method which is simple in operation, high in success rate and reliable in result is provided for establishing a stable premature ovarian failure animal model for basic research.

Description

technical field [0001] The invention relates to a method for using cisplatin to establish a premature ovarian failure model in rats. Background technique [0002] Premature ovarian failure (POF) refers to a disease characterized by amenorrhea, infertility, estrogen deficiency and elevated gonadotropin levels in women before the age of 40. The incidence rate is 1% to 3% in the general population, 4% to 8% in women with secondary amenorrhea, and 0.01% before the age of 20. In recent years, the incidence of POF in women of reproductive age has been increasing year by year and tends to be younger. Due to the decrease in the amount of estrogen secreted by ovaries in patients with premature ovarian failure, it can lead to some other diseases, such as osteoporosis and genitourinary atrophy. , Lipid metabolism disorder, cardiovascular disease. [0003] Cisplatin, also known as cisplatin, cisplatin, DDP, tin platinum, is a metal platinum complex commonly used at present, and the pl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): A01K67/02
CPCA01K67/02A01K2207/20A01K2227/105A01K2267/03
Inventor刘鹏安文强刘新杨晓帅曹启龙陆曼薛金嫚万娜秦娇
Owner北京银丰鼎诚生物工程技术有限公司